D.E. Shaw & Co
IRMD icon

D.E. Shaw & Co’s iRadimed IRMD Stock Holding History

D.E. Shaw & Co’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
+18,043
New +$1.8M ﹤0.01% 3022
2025
Q4 		– Sell
-10,256
Closed -$730K – 4795
2025
Q3 		$730K Buy
10,256
+2,393
+30% +$159K ﹤0.01% 3654
2025
Q2 		$470K Sell
7,863
-1,289
-14% -$70.6K ﹤0.01% 3668
2025
Q1 		$480K Sell
9,152
-3,996
-30% -$225K ﹤0.01% 3531
2024
Q4 		$723K Sell
13,148
-2,801
-18% -$147K ﹤0.01% 3403
2024
Q3 		$802K Buy
15,949
+7,747
+94% +$357K ﹤0.01% 3420
2024
Q2 		$360K Buy
+8,202
New +$349K ﹤0.01% 3800
2022
Q2 		– Sell
-11,620
Closed -$521K – 5534
2022
Q1 		$521K Buy
+11,620
New +$537K ﹤0.01% 4347

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's IRMD Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in iRadimed (IRMD) in Q1 2026: 18,043 shares worth $1.74M. The stake represents ﹤0.01% of the portfolio and ranks #3022 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in IRMD as recently as Q3 2025.

D.E. Shaw & Co first reported a position in IRMD in Q1 2022 and has held it in 8 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • D.E. Shaw & Co held 18,043 shares of iRadimed worth $1.74M as of Q1 2026.
  • iRadimed was a new D.E. Shaw & Co position in Q1 2026.
  • iRadimed made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3022 holding.
  • D.E. Shaw & Co first reported a position in iRadimed in Q1 2022 and has held it in 8 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.